跳至主要内容
临床试验/NCT06046118
NCT06046118招募中不适用

Outcomes of Photobiomodulation in DRy Age Related macUlar Degeneration: a proSpective multicEnter raNdomized Controlled (DRUSEN) Study

Azienda Ospedaliera Universitaria Mater Domini, Catanzaro7 个研究点 分布在 4 个国家目标入组 180 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
180
试验地点
7
主要终点
Drusen Volume Variation

研究概览

简要总结

The goal of this clinical trial is to evaluate effects of consecutive Yellow and Red Light Emitting Diode photobiomodulation in dry age-related macular degeneration (AMD). The main questions it aims to answer are:

  • Is Yellow and Red Light Emitting Diode photobiomodulation effective in decreasing drusen volume in patients affected by dry AMD?
  • Does Yellow and Red Light Emitting Diode photobiomodulation increase visual acuity and contrast sensitivity in patients affected by dry AMD? Participants will be randomly assigned to a treatment or a sham group.

Treatment consists in two cycles with two phases each:

  • 1st phase: 300 seconds of continuous Yellow light with eyes closed + 60 seconds of pulsed Yellow light with eyes opened;
  • 2d phase: 300 seconds of continuous Red light with eyes closed + 60 seconds of pulsed Red light with eyes opened.

Cycle 1 consists of 8 sessions (two PBM per week for 4 weeks) and cycle 2 consists of 6 sessions (two PBM per week for 3 weeks).

Researchers will compare patients in the treatment group to those in the sham group to evaluate differences in objective signs and subjective symptoms of dry AMD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BCVA ETDRS > 40 L ETDRS at 4 meters
  • Diagnosis of DRY AMD AREDS grade 2-3
  • Ability to communicate well with the investigator and able to understand and comply with the requirements of the study

排除标准

  • Concomitant epilepsy
  • Neurological diseases
  • Psychiatric pathologies
  • Herpes virus infections
  • Dense cataract
  • Pregnancy
  • Other significant ocular and/or retinal diseases

结局指标

主要结局

Drusen Volume Variation

时间窗: 1 month, 2 months and 4 months after each cycle

Based on SD-OCT Heidelberg

Best Corrected Visual Acuity variation

时间窗: 1 month, 2 months and 4 months after each cycle

ETDRS letters

Contrast sensitivity variation

时间窗: 1 month, 2 months and 4 months after each cycle

Based on Pelli Robson chart

次要结局

未报告次要终点

研究者

发起方
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuseppe Giannaccare

Professor

Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

研究点 (7)

Loading locations...

相似试验